Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Neurology, Neurosurgery, and Psychiatry 2003;74:287-288; doi:10.1136/jnnp.74.3.287
Copyright © 2003 by the BMJ Publishing Group Ltd.
Journal of Neurology Neurosurgery and Psychiatry 2003;74:287-288
© 2003 BMJ Publishing Group

EDITORIAL COMMENTARY

Parkinson’s disease

Objective measures for the progression of Parkinson’s disease

B Snow

Auckland Hospital, New Zealand;
bsnow@adhb.govt.nz


Objective measure of the nigrostriatal dopaminergic deficit: evidence that SPECT does the job

Keywords: Parkinson’s disease; SPECT; PET

The first 150 words of the full text of this article appear below.

A persisting frustration in the diagnosis, treatment, and research of Parkinson’s disease is the lack of an objective measure of the nigrostriatal dopaminergic deficit. In particular, we need a tool to monitor the progress of the neuronal degeneration. This is very difficult to achieve clinically in Parkinson’s disease because of the complex clinical presentation and the confounding effect of symptomatic therapy. Although PET, with markers of presynaptic dopaminergic function such as 6-fluorodopa, is an accepted measuring tool, PET is complex, expensive, cumbersome, and not widely available. The alternative is SPECT, and Winogrodzka et al on pp 294–2981 of this issue provide evidence that SPECT does the job.

Winogrodzka et al took 50 patients with Parkinson’s disease and performed SPECT scans 12 months apart. For their tracer, they chose [123I] ß-CIT, which binds to the presynaptic dopamine transporters. They showed an 8% decline in binding density. This matches . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

[123I]ß-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease
A Winogrodzka, P Bergmans, J Booij, E A van Royen, J C Stoof, and E C Wolters
J. Neurol. Neurosurg. Psychiatry 2003 74: 294-298. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs

Neurology and neurosurgery jobs